01.10.2014 • News

LyondellBasell CEO Gallogly to Retire in 2015

James Gallogly, CEO of LyondellBasell since May 2009, will retire in early 2015, the company has announced.

A committee of the supervisory board has been appointed to find a successor.

The contract of the 61-year-old executive, who steered LyondellBasell through its post-bankruptcy reorganization, was last renewed for four years in May of this year. However, "having achieved the goals that I set for myself professionally and for the company," Gallogly said, "I feel it is time to move on to the next chapter.

Collectively appointed to four-year terms in May, "the entire management board has demonstrated exceptional business leadership and I am confident the transition will be seamless," the retiring CEO added.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Top-Feature

most read